Title  | Date  | Price |
|---|
Private Hospitals & Clinics
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Healthcare Industry in United States
| Apr 2009 |
£270 |
Healthcare Industry in Australia: PEST Framework Analysis
| Apr 2009 |
£140 |
Hospital Furniture
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Hospital Equipment & Supplies
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Healthcare Consultants
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Ambulance Services
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Foster Care
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Healthcare Distribution and Services Industry in the US - PEST Framework Analysis
| Apr 2009 |
£150 |
Healthcare Preparations
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Care Homes
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Physiotherapy Equipment
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Mental Health Centres
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Childrens Homes
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Healthcare
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Health Care Services
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Disability Care Services
Plimsoll Portfolio Analysis
| Apr 2009 |
£350 |
Private healthcare market in Central and Eastern Europe 2009
Development forecasts 2009-2011
| Mar 2009 |
£2,285 |
InvestFrost Healthcare - Investment Themes
| Mar 2009 |
£3,605 |
Freedonia Focus on Elder Care Services
| Mar 2009 |
£310 |
Medicaid Rebates: The Cost of Noncompliance
| Mar 2009 |
£900 |
U.S. Glaucoma Pharmaceuticals Market
| Mar 2009 |
£3,605 |
An Overview of the Healthcare Industry in Ghana
| Mar 2009 |
£4,510 |
Asia-Pacific Enterprise Communications in the Hospitality
| Mar 2009 |
£7,215 |
Hospital Market - India
| Mar 2009 |
£350 |
Any Stimulus in the Stimulus Plan for the Healthcare Payer?
| Mar 2009 |
£900 |
Healthcare in a Recession
(OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
| Mar 2009 |
£1,200 |
European Bone and Joint Health Ingredients Market
| Mar 2009 |
£3,755 |
Healthcare Industry in Germany-2009
| Mar 2009 |
£600 |
Retail Clinics and The in-Store Healthcare Market 2009
Bright Spot in The Current Economy?
| Mar 2009 |
£2,105 |
Crisis and Care Accommodation in Australia
IBISWorld Industry Report
| Mar 2009 |
£340 |
Indian Baby Care Market to 2013
| Mar 2009 |
£180 |
Pathology Services in Australia
IBISWorld Industry Report
| Mar 2009 |
£340 |
Patient Monitoring Industry
Focus on Capnography Market
| Mar 2009 |
£455 |
Hospital Information Systems
| Feb 2009 |
£2,375 |
Psychiatric Hospitals in Australia
IBISWorld Industry Report
| Feb 2009 |
£340 |
Substance Abuse & Mental Health Facilities in the US
IBISWorld Industry Report
| Feb 2009 |
£390 |
Negotiating The Emerging Biosimilars Landscape
Key Developments in The Regulatory Environment
| Feb 2009 |
£1,730 |
Technology Transfer Strategies: Maximizing the returns from new technologies
| Feb 2009 |
£2,305 |
Pediatric Health Care Products and Services
| Jan 2009 |
£2,915 |
Research Report on China's Condom Market, 2009
| Jan 2009 |
£1,240 |
Freedonia Focus on Home Medical Equipment
| Jan 2009 |
£310 |
Anti-Aging Products
| Jan 2009 |
£2,675 |
Strategic Analysis of the Healthcare Industry in Tanzania
| Jan 2009 |
£4,510 |
2009 Trendology: U.S. Offices of Physicians
| Jan 2009 |
£240 |
General Practitioner Family Doctors in the US
IBISWorld Industry Report
| Dec 2008 |
£390 |
Global Medical Tourism
| Dec 2008 |
£1,235 |
Optometrists in the US
IBISWorld Industry Report
| Dec 2008 |
£390 |
Strategic Analysis of the Healthcare Industry in Kenya
| Dec 2008 |
£4,510 |
Stakeholder Opinions: Sarcomas
| Dec 2008 |
£2,285 |
Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice?
| Dec 2008 |
£18,275 |
Stakeholder Insight: Spondyloarthropathies - Disease perception limits market potential
| Dec 2008 |
£7,955 |
Why Do Drugs Fail?
| Nov 2008 |
£995 |
2009 Trendology: U.S. Medical & Surgical Hospitals
| Nov 2008 |
£240 |
Youth Programs & Miscellaneous Care Facilities in the US
IBISWorld Industry Report
| Nov 2008 |
£390 |
Clinical Laboratory Services Market
(Growth Opportunities, Competitive Analysis and Competitor Profiles)
| Nov 2008 |
£1,505 |
Psychiatric Hospitals in the US
IBISWorld Industry Report
| Nov 2008 |
£390 |
Trends & Strategies in Weight Management: Ten
Key Case Studies
| Nov 2008 |
£256 |
MarketWatch: Health Roundup
| Nov 2008 |
£240 |
Physiotherapy Services in Australia
IBISWorld Industry Report
| Nov 2008 |
£345 |
Solutions to Watch for in Healthcare Payers Communications
The Next Big Thing
| Nov 2008 |
£900 |
Chiropractic Services in Australia
IBISWorld Industry Report
| Nov 2008 |
£345 |
Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth
| Oct 2008 |
£9,270 |
Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
| Oct 2008 |
£8,070 |
Stakeholder Insight: Osteoporosis - Generic alendronate further establishes oral bisphosphonates as gold standard
| Oct 2008 |
£8,070 |
North American Fetal and Neonatal Patient Monitoring Markets
| Oct 2008 |
£4,510 |
RNA therapy: the next big thing after monoclonal antibodies?
| Oct 2008 |
£4,635 |
2009 U.S. Nursing Care Facilities Industry Report
| Oct 2008 |
£90 |
Healthcare Industry in MEA
IT Market Assessment
| Oct 2008 |
£600 |
2009 U.S. Medical & Surgical Hospitals Industry Report
| Oct 2008 |
£90 |
Strategic Opportunities for the Biofuel Industry in Key Sub-Saharan African Countries
| Oct 2008 |
£4,510 |
Pharmaceutical Contract Manufacturing
| Oct 2008 |
£2,375 |
Healthcare Industry in North America
IT Market Assessment
| Oct 2008 |
£600 |
2009 U.S. Offices of Dentists Industry Report
| Oct 2008 |
£90 |
Health Care Equipment & Supplies: Global Industry Guide
| Oct 2008 |
£900 |
Healthcare Industry in Latin America
IT Market Assessment
| Oct 2008 |
£600 |
2009 U.S. Home Health Care Services Industry Report
| Oct 2008 |
£90 |
2009 U.S. Offices of Physicians Industry Report
| Oct 2008 |
£90 |
Healthcare Industry in APAC
IT Market Assessment
| Oct 2008 |
£600 |
Healthcare Industry in Europe
IT Market Assessment
| Oct 2008 |
£600 |
Indian Healthcare - New Avenues for Growth
| Oct 2008 |
£480 |
2009 U.S. Community Care Facilities for the Elderly Industry Report
| Oct 2008 |
£90 |
Western Europe, Healthcare Sector Pulse, April-June 2008
| Sep 2008 |
£865 |
Aging Population in the Western World - Investment Opportunities
| Sep 2008 |
£3,605 |
World Healthcare Security Market
| Sep 2008 |
£6,010 |
Sales Force Effectiveness
| Sep 2008 |
£4,635 |
Healthcare Services
| Sep 2008 |
£570 |
Emerging Opportunities with Cannabinoids
| Sep 2008 |
£795 |
Trends in Pharmaceutical Portfolio Management
Strategies to Maintain Profitability despite Adversity
| Sep 2008 |
£2,315 |
Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
| Sep 2008 |
£8,070 |
British National Formulary
| Sep 2008 |
£28 |
Financial Deals Industry Tracker: Pharmaceuticals and Healthcare August 2008
(Analysis of Merger and Acquisition (M&A), Private Equity, Venture Financing, Private Placement, Initial Public Offering (Ipo), and Secondary Offering Deals)
| Sep 2008 |
£300 |
Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary
Diverse Drugs Approaching The Market for Many Tumor Types
| Sep 2008 |
£6,950 |
Trends in Clinical Trials: Strategies to Enhance Clinical Trial Design
| Sep 2008 |
£2,315 |
Medical Tourism Facts and Figures 2008
| Sep 2008 |
£600 |
Telemedicine Gets a Big Boost from the Feds
| Aug 2008 |
£2,705 |
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
| Aug 2008 |
£595 |
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects
| Aug 2008 |
£1,495 |
Cancer Biomarkers: Players, products and prospects (Volume I)
| Aug 2008 |
£595 |
first
previous
